Market Research Logo

Global Clostridium Diagnostics Market 2017-2021

Global Clostridium Diagnostics Market 2017-2021

About Clostridium Diagnostics

Clostridium is a gram-positive bacteria that belongs to the Firmicutes phylum. There are multiple species of Clostridium — Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Clostridium tetani, and Clostridium sordellii, which are responsible for numerous infections. Clostridium tetani is responsible for tetanus, Clostridium botulinum causes botulism, Clostridium perfringes leads to gas gangrene, Clostridium sortellii causes pneumonia, endocarditis, arthritis, peritonitis, and myonecrosis, and Clostridium difficile is responsible for diarrhea. Technavio’s analysts forecast the global clostridium diagnostics market to grow at a CAGR of 14.71% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global clostridium diagnostics market for 2017-2021. To calculate the market size, the report considers the sales/volume/value.The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Clostridium Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abbott
  • Beckman Coulter
  • Olympus
  • Siemens Healthineers
  • F. Hoffmann-La Roche
Other prominent vendors
  • BD
  • bioMerieux
  • Chrono-log Corporation
  • Corgenix
  • Diazyme Laboratories
  • FUJIREBIO DIAGNOSTICS
  • Hologic
  • QIAGEN
  • Sysmex Corporation
  • Thermo Fisher Scientific
Market driver
  • Rising prevalence of Clostridium-related diseases
  • For a full, detailed list, view our report
Market challenge
  • High cost of molecular diagnostics over immunoassays
  • For a full, detailed list, view our report
Market trend
  • Technological advancements
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Releases

Technavio Announces the Publication of its Research Report – Global Clostridium Diagnostics Market 2017-2021

Technavio recognizes the following companies as the key players in the global clostridium diagnostics market : Abbott, Beckman Coulter, Olympus, Siemens Healthineers, and F. Hoffmann-La Roche.

Other Prominent Vendors in the market are: BD, bioMerieux, Chrono-log Corporation, Corgenix, Diazyme Laboratories, FUJIREBIO DIAGNOSTICS, Hologic, QIAGEN, Sysmex Corporation, and Thermo Fisher Scientific.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is technological advancements. The use of automation and robots in clinical laboratories has become more prevalent today. The pressure on the laboratories to produce faster results and reduce errors to improve patient care has increased. The current technologies in laboratory automation can automate specimen transportation, sorting, accessioning, and inspection. Over the decade, the pressure to reduce healthcare costs has increased, and hence, laboratories are relying on automation to maintain profitability. Currently, over 30% of laboratories in Japan, Europe, and North America has implemented a significant degree of laboratory automation.”

According to the report, one of the major drivers for this market is Rising prevalence of Clostridium-related diseases. Clostridium difficile infection (CDI) is a major cause of hospital-associated GI illness and creates a huge burden on the healthcare system. It is estimated that patients with CDI put a burden of $3.2 billion annually in the US on the healthcare system. Patients with CDI have a longer stay at the hospital, and CDI has been the major cause of large outbreaks of diseases in hospitals. The new molecular diagnostic stool test will replace the current enzyme immunoassay tests.

Further, the report states that one of the major factors hindering the growth of this market is High cost of molecular diagnostics over immunoassays. Most of the tests done for the diagnosis of Clostridium-related infections are immunoassay tests as they are cost-effective. Immunoassays are quick and accurate tests and can be done on-site, as well as, in the laboratory. The tests are very effective in detecting several infections. Every year out of 100 cases, 30 cases go undiagnosed. With 30% chances of missing the diagnosis, the other preferable option is molecular diagnostics that offer high accuracy. With several organizations preferring molecular diagnostics over immunoassays, patients have to incur high costs.

Companies Mentioned

Abbott, Beckman Coulter, Olympus, Siemens Healthineers, F. Hoffmann-La Roche, BD, bioMerieux, Chrono-log Corporation, Corgenix, Diazyme Laboratories, FUJIREBIO DIAGNOSTICS, Hologic, QIAGEN, Sysmex Corporation, and Thermo Fisher Scientific.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • MARKET OUTLINE
      • Table Global Clostridium diagnostics market: Overview
  • Market landscape
    • MARKET OVERVIEW
      • Table Human pathogenic Clostridium species
    • MARKET SIZE AND FORECAST
      • Table Global Clostridium diagnostics market 2016-2021 ($ millions)
    • FIVE FORCES ANALYSIS
      • Table Five forces analysis
  • Market segmentation by technology
    • Table Global Clostridium diagnostics market by technology 2016 (%)
    • IMMUNOASSAYS
      • Table Global immunoassays market: Overview
      • Table Global Clostridium diagnostics market by immunoassays 2016-2021 ($ millions)
      • Table Diagnostic tests for Clostridium difficile
    • MOLECULAR DIAGNOSTICS
      • Table Global molecular diagnostics market: Overview
      • Table Global Clostridium diagnostics market by molecular diagnostics 2016-2021 ($ millions)
      • Table FDA-approved nucleic acid-based tests for diagnosis of Clostridium difficile
  • Market segmentation by product
    • CLOSTRIDIUM DIFFICILE
      • Table Global Clostridium difficile diagnostics market 2016-2021 ($ millions)
    • CLOSTRIDIUM PERFRINGENS
      • Table Global Clostridium perfringens diagnostics market 2016-2021 ($ millions)
    • CLOSTRIDIUM BOTULINUM
      • Table Global Clostridium botulinum diagnostics market 2016-2021 ($ millions)
    • CLOSTRIDIUM TETANI
      • Table Global Clostridium tetani diagnostics market 2016-2021 ($ millions)
    • CLOSTRIDIUM SORDELLII
      • Table Global Clostridium sordellii diagnostics market 2016-2021 ($ millions)
  • Market segmentation by end-user
    • HOSPITALS
    • INDEPENDENT LABORATORIES
    • PHYSICIANS' CLINICS
  • Geographical segmentation
    • MARKET OVERVIEW
      • Table Global Clostridium diagnostics market by geography 2016 (%)
      • Table Global Clostridium diagnostics market by geography 2021 (%)
      • Table Global Clostridium diagnostics market by geography 2016-2021 ($ millions)
      • Table Global Clostridium diagnostics market by geography 2016-2021 (%)
    • AMERICAS
      • Table Clostridium diagnostics market in Americas ($ millions)
      • Table Clostridium diagnostics market in US: Overview
    • EMEA
      • Table Clostridium diagnostics market in EMEA ($ millions)
      • Table Clostridium diagnostics market in Germany: Overview
    • APAC
      • Table Clostridium diagnostics market in APAC ($ millions)
      • Table Clostridium diagnostics market in Japan: Overview
  • Decision framework
  • Drivers and challenges
    • MARKET DRIVERS
    • MARKET CHALLENGES
  • Market trends
    • TECHNOLOGICAL ADVANCEMENTS
    • INCREASING FOCUS ON REDUCING NOSOCOMIAL INFECTIONS
    • GROWING POPULARITY OF PORTABLE POCT PRODUCTS
  • Vendor landscape
    • COMPETITIVE LANDSCAPE
  • Key vendor analysis
    • ABBOTT
      • Table Abbott: Key highlights
      • Table Abbott: Strength assessment
      • Table Abbott: Strategy assessment
      • Table Abbott: Opportunity assessment
    • BECKMAN COULTER
      • Table Beckman Coulter: Key highlights
      • Table Beckman Coulter: Strength assessment
      • Table Beckman Coulter: Strategy assessment
      • Table Beckman Coulter: Opportunity assessment
    • OLYMPUS CORPORATION
      • Table Olympus Corporation: Key highlights
      • Table Olympus Corporation: Strength assessment
      • Table Olympus Corporation: Strategy assessment
      • Table Olympus Corporation: Opportunity assessment
    • SIEMENS HEALTHINEERS
      • Table Siemens Healthineers: Key highlights
      • Table Siemens Healthineers: Strength assessment
      • Table Siemens Healthineers: Strategy assessment
      • Table Siemens Healthineers: Opportunity assessment
    • F. HOFFMANN-LA ROCHE
      • Table F. Hoffmann-La Roche: Key highlights
      • Table F. Hoffmann-La Roche: Strength assessment
      • Table F. Hoffmann-La Roche: Strategy assessment
      • Table F. Hoffmann-La Roche: Opportunity assessment
    • OTHER PROMINENT VENDORS
  • Appendix
    • LIST OF ABBREVIATIONS
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report